Your browser doesn't support javascript.
loading
Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation.
Burkly, L C; Jakubowski, A; Newman, B M; Rosa, M D; Chi-Rosso, G; Lobb, R R.
  • Burkly LC; Biogen, Inc., Cambridge, MA 02142.
Eur J Immunol ; 21(11): 2871-5, 1991 Nov.
Article en En | MEDLINE | ID: mdl-1718763
ABSTRACT
Vascular cell adhesion molecule, VCAM-1, is an adhesion molecule expressed on activated endothelium thought to play a role in leukocyte migration to sites of inflammation. VCAM-1 adheres to leukocytes through the VLA-4 integrin. Recombinant soluble VCAM-1 (rsVCAM) and anti-CD3 mAb OKT3 were utilized to address the role of the VCAM-1/VLA-4 pathway in antigen-dependent T cell activation. Monocyte-depleted T cells proliferated upon exposure to co-immobilized OKT3 and rsVCAM but to neither alone. In contrast, an anti-VLA-4 mAb HP1/2 failed to co-activate with OKT3, despite the fact that both rsVCAM and HP1/2 support T cell adhesion comparably. These data indicate that adhesive function is not sufficient for co-stimulatory activity. They also reveal that VCAM-1 may play a role in regulating T cell immune responses as well as migration in vivo.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Activación de Linfocitos / Receptores de Antígenos de Linfocitos T / Linfocitos T / Antígenos de Diferenciación de Linfocitos T / Antígenos CD / Moléculas de Adhesión Celular / Receptores de Antígeno muy Tardío Límite: Humans Idioma: En Año: 1991 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Activación de Linfocitos / Receptores de Antígenos de Linfocitos T / Linfocitos T / Antígenos de Diferenciación de Linfocitos T / Antígenos CD / Moléculas de Adhesión Celular / Receptores de Antígeno muy Tardío Límite: Humans Idioma: En Año: 1991 Tipo del documento: Article